IFI27L2
gene geneOn this page
Also known as TLH29
Summary
IFI27L2 (interferon alpha inducible protein 27 like 2, HGNC:19753) is a protein-coding gene on chromosome 14q32.12, encoding Interferon alpha-inducible protein 27-like protein 2 (Q9H2X8). Plays a role in the apoptotic process and has a pro-apoptotic activity.
Predicted to enable molecular adaptor activity. Involved in apoptotic process. Located in mitochondrial membrane.
Source: NCBI Gene 83982 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 31 total — 1 pathogenic
- MANE Select transcript:
NM_032036
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19753 |
| Approved symbol | IFI27L2 |
| Name | interferon alpha inducible protein 27 like 2 |
| Location | 14q32.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | TLH29 |
| Ensembl gene | ENSG00000119632 |
| Ensembl biotype | protein_coding |
| OMIM | 611319 |
| Entrez | 83982 |
Gene structure
Transcript identifiers
Ensembl transcripts: 12 — 8 protein_coding, 4 retained_intron
ENST00000238609, ENST00000553601, ENST00000554909, ENST00000555558, ENST00000556552, ENST00000556727, ENST00000940074, ENST00000940075, ENST00000940076, ENST00000940077, ENST00000940078, ENST00000940079
RefSeq mRNA: 1 — MANE Select: NM_032036
NM_032036
CCDS: CCDS9920
Canonical transcript exons
ENST00000238609 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001098365 | 94129558 | 94129604 |
| ENSE00003483103 | 94128514 | 94128675 |
| ENSE00003617045 | 94127781 | 94127992 |
| ENSE00003643101 | 94129262 | 94129291 |
Expression profiles
Bgee: expression breadth ubiquitous, 137 present calls, max score 98.87.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 39.7417 / max 212.5914, expressed in 1773 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 144679 | 36.8553 | 1772 |
| 144680 | 1.2083 | 803 |
| 144677 | 0.7155 | 456 |
| 144678 | 0.6472 | 350 |
| 144681 | 0.3154 | 167 |
Top tissues by expression
137 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| C1 segment of cervical spinal cord | UBERON:0006469 | 98.87 | gold quality |
| substantia nigra | UBERON:0002038 | 98.80 | gold quality |
| hypothalamus | UBERON:0001898 | 98.68 | gold quality |
| temporal lobe | UBERON:0001871 | 98.55 | gold quality |
| amygdala | UBERON:0001876 | 98.55 | gold quality |
| Ammon’s horn | UBERON:0001954 | 98.33 | gold quality |
| right adrenal gland | UBERON:0001233 | 98.19 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 98.14 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 97.93 | gold quality |
| left adrenal gland | UBERON:0001234 | 97.88 | gold quality |
| nucleus accumbens | UBERON:0001882 | 97.82 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 97.82 | gold quality |
| apex of heart | UBERON:0002098 | 97.71 | gold quality |
| putamen | UBERON:0001874 | 97.63 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 97.58 | gold quality |
| pituitary gland | UBERON:0000007 | 97.39 | gold quality |
| caudate nucleus | UBERON:0001873 | 97.34 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 97.31 | gold quality |
| monocyte | CL:0000576 | 97.25 | gold quality |
| leukocyte | CL:0000738 | 97.14 | gold quality |
| adenohypophysis | UBERON:0002196 | 97.13 | gold quality |
| tibial nerve | UBERON:0001323 | 97.12 | gold quality |
| ascending aorta | UBERON:0001496 | 97.11 | gold quality |
| thoracic aorta | UBERON:0001515 | 97.11 | gold quality |
| brain | UBERON:0000955 | 97.08 | gold quality |
| cerebral cortex | UBERON:0000956 | 97.05 | gold quality |
| adrenal gland | UBERON:0002369 | 97.05 | gold quality |
| right frontal lobe | UBERON:0002810 | 96.97 | gold quality |
| right atrium auricular region | UBERON:0006631 | 96.97 | gold quality |
| left ovary | UBERON:0002119 | 96.96 | gold quality |
Single-cell (SCXA)
Detected in 4 experiment(s), a significant marker in 3.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 11.94 |
| E-CURD-112 | yes | 5.81 |
| E-HCAD-10 | yes | 4.36 |
| E-GEOD-125970 | no | 8.69 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (3): IFI6 (ENSG00000126709), IFI27L1 (ENSG00000165948), IFI27 (ENSG00000165949)
Protein
Protein identifiers
Interferon alpha-inducible protein 27-like protein 2 — Q9H2X8 (reviewed: Q9H2X8)
Alternative names: Interferon-stimulated gene 12b protein, Protein TLH29, pIFI27-like protein
All UniProt accessions (2): Q9H2X8, A0A0B4J270
UniProt curated annotations — full annotation on UniProt →
Function. Plays a role in the apoptotic process and has a pro-apoptotic activity.
Subcellular location. Mitochondrion membrane.
Induction. Not up-regulated by type-I interferon.
Similarity. Belongs to the IFI6/IFI27 family.
RefSeq proteins (1): NP_114425* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009311 | IFI6/IFI27-like | Family |
| IPR038213 | IFI6/IFI27-like_sf | Homologous_superfamily |
Pfam: PF06140
UniProt features (5 total): transmembrane region 3, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H2X8-F1 | 54.73 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 145 (showing top):
HUMMERICH_MALIGNANT_SKIN_TUMOR_DN, BOYLAN_MULTIPLE_MYELOMA_D_DN, FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN, MARTINEZ_RB1_TARGETS_UP, GOBP_APOPTOTIC_SIGNALING_PATHWAY, INGRAM_SHH_TARGETS_UP, YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6, GOCC_MITOCHONDRIAL_ENVELOPE, GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY, MARTINEZ_RB1_AND_TP53_TARGETS_UP, HAN_JNK_SINGALING_UP, chr14q32, NUYTTEN_EZH2_TARGETS_DN, CASTELLANO_NRAS_TARGETS_UP, COLINA_TARGETS_OF_4EBP1_AND_4EBP2
GO Biological Process (2): apoptotic process (GO:0006915), intrinsic apoptotic signaling pathway (GO:0097193)
GO Molecular Function (1): molecular adaptor activity (GO:0060090)
GO Cellular Component (3): mitochondrion (GO:0005739), mitochondrial membrane (GO:0031966), membrane (GO:0016020)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| apoptotic signaling pathway | 2 |
| programmed cell death | 1 |
| execution phase of apoptosis | 1 |
| intracellular signal transduction | 1 |
| molecular_function | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| mitochondrion | 1 |
| mitochondrial envelope | 1 |
| organelle membrane | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
690 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| IFI27L2 | RSAD2 | Q8WXG1 | 405 |
| IFI27L2 | IFIT5 | Q13325 | 394 |
| IFI27L2 | IFITM10 | A6NMD0 | 365 |
| IFI27L2 | TMEM168 | Q9H0V1 | 327 |
| IFI27L2 | ISG15 | P05161 | 323 |
| IFI27L2 | TLCD1 | Q96CP7 | 318 |
| IFI27L2 | IFITM2 | Q01629 | 316 |
| IFI27L2 | OCEL1 | Q9H607 | 314 |
| IFI27L2 | IRF1 | P10914 | 314 |
| IFI27L2 | IFIH1 | Q9BYX4 | 313 |
| IFI27L2 | GOLGB1 | Q14789 | 312 |
| IFI27L2 | A0A2U3TZT1 | A0A2U3TZT1 | 310 |
| IFI27L2 | IFI44L | Q53G44 | 305 |
| IFI27L2 | IFITM3 | Q01628 | 301 |
| IFI27L2 | MX1 | P20591 | 294 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FCN1 | IFI27L2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TFAP2A | IFI27L2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TFAP2C | IFI27L2 | psi-mi:“MI:0915”(physical association) | 0.370 |
| IFI27L2 | TFAP2C | psi-mi:“MI:0915”(physical association) | 0.370 |
| CELF1 | IFI27L2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| IFI27L2 | psi-mi:“MI:0915”(physical association) | 0.000 |
ESM2 similar proteins: A0A0H2XIV9, A0L9X3, B0KTG9, B1I892, B5E1Z4, B8ZNI6, C0HL68, C1C9E8, C1CGA6, C1CMJ2, C1CTB2, O26106, O31557, P07579, P09912, P0A3K0, P0A3K1, P0C8T8, P0DTW2, P0DY15, P19407, P34306, P34327, P34677, P40843, P58316, P67293, P67294, P75617, P77354, P80967, P83313, P84841, P86018, P86155, Q04IS6, Q18EC3, Q24JY7, Q28808, Q2G179
Diamond homologs: P09912, P40305, Q24JY7, Q28808, Q6IED8, Q8R412, Q8VC49, Q96BM0, Q9H2X8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 19 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 443977 | GRCh37/hg19 14q11.2-32.33(chr14:20511673-107285437) | Pathogenic |
SpliceAI
351 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 14:94128671:CAGGG:C | acceptor_gain | 1.0000 |
| 14:94128673:GGG:G | acceptor_gain | 1.0000 |
| 14:94128674:GG:G | acceptor_gain | 1.0000 |
| 14:94128675:GCTG:G | acceptor_loss | 1.0000 |
| 14:94128676:C:CA | acceptor_loss | 1.0000 |
| 14:94128676:C:CC | acceptor_gain | 1.0000 |
| 14:94129556:A:AC | donor_gain | 1.0000 |
| 14:94129557:C:CC | donor_gain | 1.0000 |
| 14:94129557:CT:C | donor_gain | 1.0000 |
| 14:94129557:CTCAT:C | donor_gain | 1.0000 |
| 14:94129561:T:C | donor_gain | 1.0000 |
| 14:94128507:CACT:C | donor_loss | 0.9900 |
| 14:94128508:ACTTA:A | donor_loss | 0.9900 |
| 14:94128509:CTTA:C | donor_loss | 0.9900 |
| 14:94128510:TTA:T | donor_loss | 0.9900 |
| 14:94128511:T:TG | donor_loss | 0.9900 |
| 14:94128512:A:AC | donor_gain | 0.9900 |
| 14:94128512:AC:A | donor_gain | 0.9900 |
| 14:94128513:C:CC | donor_gain | 0.9900 |
| 14:94128513:C:CT | donor_loss | 0.9900 |
| 14:94128513:CC:C | donor_gain | 0.9900 |
| 14:94128513:CCCA:C | donor_gain | 0.9900 |
| 14:94128672:AGGG:A | acceptor_gain | 0.9900 |
| 14:94128675:GCTGT:G | acceptor_gain | 0.9900 |
| 14:94129554:TCACT:T | donor_loss | 0.9900 |
| 14:94129555:CACTC:C | donor_loss | 0.9900 |
| 14:94129556:ACT:A | donor_gain | 0.9900 |
| 14:94129557:C:A | donor_loss | 0.9900 |
| 14:94129557:CTC:C | donor_gain | 0.9900 |
| 14:94129557:CTCA:C | donor_gain | 0.9900 |
AlphaMissense
809 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 14:94128629:G:C | F28L | 0.994 |
| 14:94128629:G:T | F28L | 0.994 |
| 14:94128631:A:G | F28L | 0.994 |
| 14:94128539:G:C | S58R | 0.980 |
| 14:94128539:G:T | S58R | 0.980 |
| 14:94128541:T:G | S58R | 0.980 |
| 14:94128630:A:G | F28S | 0.978 |
| 14:94128597:G:T | A39E | 0.969 |
| 14:94128630:A:C | F28C | 0.966 |
| 14:94128634:C:G | G27R | 0.963 |
| 14:94128584:C:A | M43I | 0.953 |
| 14:94128584:C:G | M43I | 0.953 |
| 14:94128584:C:T | M43I | 0.953 |
| 14:94128603:G:A | S37F | 0.949 |
| 14:94128521:C:A | Q64H | 0.941 |
| 14:94128521:C:G | Q64H | 0.941 |
| 14:94129265:C:G | G12R | 0.938 |
| 14:94129265:C:T | G12R | 0.938 |
| 14:94128531:G:T | A61D | 0.932 |
| 14:94128573:G:T | A47D | 0.932 |
| 14:94128633:C:T | G27D | 0.929 |
| 14:94127944:C:T | G83E | 0.928 |
| 14:94128525:A:G | L63P | 0.928 |
| 14:94128634:C:A | G27C | 0.928 |
| 14:94128615:A:G | I33T | 0.927 |
| 14:94128603:G:T | S37Y | 0.925 |
| 14:94128615:A:T | I33N | 0.924 |
| 14:94128520:A:G | S65P | 0.922 |
| 14:94128633:C:A | G27V | 0.919 |
| 14:94128645:A:T | L23H | 0.919 |
dbSNP variants (sampled 300 via entrez): RS1000319698 (14:94131205 C>A), RS1000604153 (14:94129832 C>G), RS1001074417 (14:94129380 G>A,T), RS1001845754 (14:94129740 GCTTGA>G), RS1002440470 (14:94128740 C>G), RS1002752441 (14:94128334 C>A,G), RS1003022745 (14:94129824 A>C), RS1004738859 (14:94128791 A>G), RS1004849379 (14:94129680 G>A,C,T), RS1006112101 (14:94130858 G>A,T), RS1006963403 (14:94130651 AT>A,ATT), RS1007272932 (14:94130344 C>G,T), RS1007420959 (14:94129533 A>G), RS1009284928 (14:94127953 G>A), RS1009290828 (14:94129348 G>A,T)
Disease associations
OMIM: gene MIM:611319 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, increases expression | 4 |
| sodium arsenite | increases expression | 2 |
| Cisplatin | affects expression, increases expression | 2 |
| Estradiol | decreases expression | 2 |
| Tetrachlorodibenzodioxin | increases expression | 2 |
| GSK-J4 | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| methylparaben | decreases expression | 1 |
| avobenzone | increases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| chloropicrin | decreases expression | 1 |
| jinfukang | increases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| bisphenol AF | decreases expression | 1 |
| Irinotecan | affects cotreatment, increases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Decitabine | affects expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects methylation | 1 |
| Doxorubicin | increases expression | 1 |
| Fluorouracil | increases expression, affects cotreatment | 1 |
| Rotenone | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.